/
/
/

Lyka Labs Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
0%8%11%-7%
----232%
3%0%-8%-13%
-60%-14%-2%-11%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
LYKALABS-BE
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,849.9₹447476 Cr3712.0762.82₹11479 Cr
9,602₹254764 Cr87.134.04128.41₹2568 Cr
4,928.5₹189423 Cr86.8516.7297.06₹2163 Cr
1,180.3₹116658 Cr25.859.4262.53₹5040 Cr
1,399₹111484 Cr33.089.7757.87₹3879 Cr
2,026.2₹109943 Cr100.556.829.25₹889 Cr
2,500₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,716₹99253 Cr26.7317.9596.84₹3505 Cr
2,100.7₹96031 Cr17.3730.95154.35₹5333 Cr
87₹312 Cr0.57-0.15-₹10 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%

Balance Sheet

Consolidated
Standalone
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Revaluation reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Jun 2015Jun 2014Mar 2013Mar 2012Sep 2010Sep 2009
₹36 Cr₹36 Cr₹33 Cr₹31 Cr₹29 Cr₹29 Cr₹29 Cr₹28 Cr₹28 Cr₹22 Cr₹23 Cr₹23 Cr₹23 Cr₹23 Cr₹23 Cr₹23 Cr₹23 Cr
₹46 L₹46 L₹9 Cr₹17 Cr₹0₹0₹0₹76 L₹76 L₹0₹0₹32 L₹0₹0₹0₹0₹0
₹56 Cr₹69 Cr₹26 Cr-₹3 Cr-₹15 Cr-₹54 Cr-₹43 Cr₹14 Cr₹21 Cr₹16 Cr₹22 Cr₹20 Cr₹30 Cr₹44 Cr₹51 Cr₹80 Cr₹59 Cr
₹56 Cr₹69 Cr₹26 Cr-₹3 Cr-₹15 Cr-₹54 Cr-₹43 Cr₹14 Cr₹19 Cr₹13 Cr₹15 Cr₹11 Cr₹18 Cr₹34 Cr₹35 Cr₹42 Cr₹39 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹1 Cr₹3 Cr₹7 Cr₹9 Cr₹12 Cr₹10 Cr₹16 Cr₹38 Cr₹20 Cr
₹92 Cr₹105 Cr₹68 Cr₹45 Cr₹13 Cr-₹26 Cr-₹14 Cr₹43 Cr₹49 Cr₹38 Cr₹45 Cr₹43 Cr₹53 Cr₹67 Cr₹74 Cr₹102 Cr₹82 Cr
-₹2 Cr-₹1 Cr₹11 L₹23 L₹15 L₹70 L-₹77 L₹3 Cr₹3 Cr₹7 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr
₹14 Cr₹10 Cr₹7 Cr₹39 L₹86 L₹151 Cr₹125 Cr₹78 Cr₹4 Cr₹35 Cr₹25 Cr₹29 Cr₹50 Cr₹54 Cr₹56 Cr₹84 Cr₹89 Cr
₹9 Cr₹9 Cr₹36 Cr₹63 Cr₹62 Cr₹71 L₹64 L₹90 L₹87 L₹84 L₹0₹0₹8 Cr₹14 Cr₹15 Cr₹30 Cr₹20 Cr
₹2 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr-₹16 Cr-₹12 Cr-₹13 Cr-₹4 Cr-₹3 Cr-₹1 Cr₹2 Cr₹1 Cr₹0₹0₹0₹0
₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹10 Cr₹19 Cr₹2 Cr₹67 L₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹85 L₹86 L₹0₹0
₹3 Cr₹65 L₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹0₹0
₹30 Cr₹26 Cr₹51 Cr₹73 Cr₹73 Cr₹149 Cr₹137 Cr₹72 Cr₹5 Cr₹39 Cr₹29 Cr₹37 Cr₹65 Cr₹72 Cr₹74 Cr₹114 Cr₹109 Cr
₹17 Cr₹15 Cr₹12 Cr₹9 Cr₹12 Cr₹15 Cr₹19 Cr₹23 Cr₹24 Cr₹39 Cr₹42 Cr₹55 Cr₹63 Cr₹43 Cr₹44 Cr₹71 Cr₹46 Cr
₹17 Cr₹15 Cr₹12 Cr₹14 Cr₹66 Cr₹23 Cr₹31 Cr₹43 Cr₹92 Cr₹73 Cr₹57 Cr₹79 Cr₹78 Cr₹44 Cr₹39 Cr₹28 Cr₹24 Cr
₹19 Cr₹15 Cr₹12 Cr₹8 Cr₹20 Cr₹10 Cr₹14 Cr₹16 Cr₹46 Cr₹50 Cr₹60 Cr₹60 Cr₹66 Cr₹59 Cr₹49 Cr₹0₹0
₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹5 Cr₹3 Cr₹4 Cr₹1 Cr₹91 L₹96 L₹75 L₹9 L₹25 L
₹54 Cr₹47 Cr₹38 Cr₹33 Cr₹99 Cr₹50 Cr₹66 Cr₹85 Cr₹167 Cr₹165 Cr₹163 Cr₹195 Cr₹208 Cr₹147 Cr₹132 Cr₹100 Cr₹70 Cr
₹175 Cr₹176 Cr₹157 Cr₹152 Cr₹186 Cr₹174 Cr₹188 Cr₹203 Cr₹225 Cr₹249 Cr₹241 Cr₹279 Cr₹329 Cr₹289 Cr₹283 Cr₹318 Cr₹263 Cr
₹37 Cr₹27 Cr₹32 Cr₹34 Cr₹43 Cr₹41 Cr₹39 Cr₹52 Cr₹41 Cr₹71 Cr₹69 Cr₹71 Cr₹49 Cr₹56 Cr₹21 Cr₹13 Cr₹24 Cr
₹48 Cr₹38 Cr₹57 Cr₹72 Cr₹130 Cr₹162 Cr₹141 Cr₹96 Cr₹113 Cr₹126 Cr₹120 Cr₹136 Cr₹163 Cr₹149 Cr₹133 Cr₹114 Cr₹109 Cr
₹202 Cr₹191 Cr₹158 Cr₹158 Cr₹177 Cr₹202 Cr₹188 Cr₹203 Cr₹155 Cr₹144 Cr₹200 Cr₹214 Cr₹248 Cr₹195 Cr₹186 Cr₹214 Cr₹163 Cr
₹115 Cr₹106 Cr₹100 Cr₹90 Cr₹83 Cr₹104 Cr₹84 Cr₹95 Cr₹39 Cr₹11 Cr₹96 Cr₹92 Cr₹86 Cr₹70 Cr₹59 Cr₹50 Cr₹44 Cr
₹87 Cr₹85 Cr₹58 Cr₹68 Cr₹94 Cr₹98 Cr₹105 Cr₹108 Cr₹116 Cr₹133 Cr₹104 Cr₹122 Cr₹162 Cr₹125 Cr₹127 Cr₹164 Cr₹119 Cr
₹2 Cr₹20 L₹22 Cr₹15 Cr₹16 Cr₹16 Cr₹17 Cr₹18 Cr₹17 Cr₹17 Cr₹17 Cr₹16 Cr₹12 Cr₹7 Cr₹11 Cr₹8 Cr₹5 Cr
₹0₹2 L₹7 L₹4 L₹89,000₹89,000₹89,000₹1 L₹23 L₹26 L₹39 L₹32 L₹30 L₹6 Cr₹6 Cr₹6 Cr₹6 Cr
₹0₹2 L₹7 L₹4 L₹89,000₹89,000₹89,000₹1 L₹23 L₹26 L₹39 L₹32 L₹30 L₹6 Cr₹6 Cr₹6 Cr₹6 Cr
₹22 Cr₹22 Cr₹25 Cr₹23 Cr₹22 Cr₹21 Cr₹19 Cr₹29 Cr₹32 Cr₹29 Cr₹24 Cr₹28 Cr₹27 Cr₹17 Cr₹16 Cr₹0₹0
₹111 Cr₹109 Cr₹106 Cr₹107 Cr₹133 Cr₹145 Cr₹152 Cr₹168 Cr₹176 Cr₹186 Cr₹159 Cr₹177 Cr₹211 Cr₹162 Cr₹168 Cr₹178 Cr₹130 Cr
₹3 L₹2 L₹2 L₹84,000₹80,000₹77,000₹75,000₹70,000₹6,000₹0₹0₹0₹0₹0₹1 L₹0₹0
₹14 Cr₹12 Cr₹10 Cr₹7 Cr₹8 Cr₹4 Cr₹7 Cr₹7 Cr₹11 Cr₹13 Cr₹11 Cr₹19 Cr₹16 Cr₹18 Cr₹16 Cr₹14 Cr₹13 Cr
₹35 Cr₹43 Cr₹27 Cr₹20 Cr₹18 Cr₹9 Cr₹8 Cr₹15 Cr₹20 Cr₹29 Cr₹43 Cr₹57 Cr₹68 Cr₹73 Cr₹61 Cr₹90 Cr₹67 Cr
₹1 Cr₹1 Cr₹6 Cr₹12 Cr₹17 Cr₹7 Cr₹10 Cr₹2 Cr₹2 Cr₹5 Cr₹6 Cr₹7 Cr₹11 Cr₹5 Cr₹2 Cr₹5 Cr₹7 Cr
₹7 Cr₹6 Cr₹3 Cr₹3 Cr₹3 Cr₹5 Cr₹7 Cr₹2 Cr₹2 Cr₹4 Cr₹5 Cr₹5 Cr₹5 Cr₹14 Cr₹5 Cr₹0₹0
₹6 Cr₹4 Cr₹5 Cr₹2 Cr₹6 Cr₹4 Cr₹4 Cr₹10 Cr₹13 Cr₹11 Cr₹17 Cr₹15 Cr₹18 Cr₹17 Cr₹31 Cr₹25 Cr₹35 Cr
₹63 Cr₹67 Cr₹51 Cr₹44 Cr₹52 Cr₹29 Cr₹36 Cr₹35 Cr₹49 Cr₹63 Cr₹82 Cr₹102 Cr₹118 Cr₹127 Cr₹115 Cr₹135 Cr₹122 Cr
₹9 Cr₹21 Cr₹13 Cr₹12 Cr-₹47 Cr-₹21 Cr-₹30 Cr-₹50 Cr-₹118 Cr-₹103 Cr-₹81 Cr-₹94 Cr-₹90 Cr-₹21 Cr-₹17 Cr₹35 Cr₹52 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹5 Cr₹11 Cr
₹175 Cr₹176 Cr₹157 Cr₹152 Cr₹186 Cr₹174 Cr₹188 Cr₹203 Cr₹225 Cr₹249 Cr₹241 Cr₹279 Cr₹329 Cr₹289 Cr₹283 Cr₹318 Cr₹263 Cr
₹26₹29₹18₹9₹5-₹9-₹5₹15₹17₹16₹17₹15₹19₹26₹26₹27₹23
₹26₹29₹18₹9₹5-₹9-₹5₹15₹17₹16₹17₹15₹19₹26₹26₹27₹23

Cash Flow

Consolidated
Standalone
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Jun 2015Jun 2014Mar 2013Mar 2012Sep 2010Sep 2009
-₹12 Cr₹11 Cr-₹93 L-₹13 Cr₹59 Cr-₹14 Cr-₹62 Cr-₹15 Cr-₹20 Cr-₹8 Cr₹4 Cr-₹5 Cr-₹7 Cr-₹71 L-₹7 Cr₹2 Cr₹0
₹20 Cr₹8 Cr₹18 Cr₹32 Cr₹42 Cr₹35 Cr₹56 Cr₹15 Cr₹21 Cr₹31 Cr₹16 Cr₹32 Cr₹33 Cr₹17 Cr₹24 Cr₹24 Cr₹0
-₹2 Cr-₹15 Cr-₹14 Cr-₹10 Cr-₹21 Cr-₹12 Cr₹11 Cr₹28 Cr₹10 Cr₹10 Cr-₹8 Cr-₹79 L₹67 Cr-₹5 Cr-₹16 Cr-₹12 Cr₹0
₹6 Cr₹5 Cr₹3 Cr₹9 Cr₹80 Cr₹10 Cr₹5 Cr₹27 Cr₹11 Cr₹33 Cr₹12 Cr₹26 Cr₹93 Cr₹11 Cr₹87 L₹14 Cr₹0
₹5 Cr₹2 Cr₹2 Cr₹9 Cr₹79 Cr₹9 Cr₹5 Cr₹27 Cr₹11 Cr₹31 Cr₹12 Cr₹27 Cr₹89 Cr₹11 Cr₹1 Cr₹15 Cr₹0
-₹9 Cr-₹12 Cr-₹9 Cr₹7 Cr-₹6 Cr-₹16 L-₹11 L-₹4 Cr-₹3 Cr-₹13 Cr₹17 Cr₹29 Cr-₹57 Cr₹5 Cr₹12 Cr-₹6 Cr₹0
₹4 Cr₹5 Cr₹2 Cr-₹22 Cr-₹63 Cr-₹12 Cr₹3 Cr-₹23 Cr-₹10 Cr-₹19 Cr-₹30 Cr-₹60 Cr-₹26 Cr-₹13 Cr-₹16 Cr-₹11 Cr₹0
₹2 L-₹5 Cr-₹6 Cr-₹5 Cr₹10 Cr-₹3 Cr₹9 Cr-₹72 L-₹3 Cr-₹43 L-₹96 L-₹4 Cr₹6 Cr₹3 Cr-₹3 Cr-₹2 Cr₹0
₹1 Cr₹6 Cr₹12 Cr₹17 Cr₹7 Cr₹10 Cr₹2 Cr₹2 Cr₹5 Cr₹6 Cr₹7 Cr₹11 Cr₹5 Cr₹2 Cr₹5 Cr₹7 Cr₹0
₹1 Cr₹1 Cr₹6 Cr₹12 Cr₹17 Cr₹7 Cr₹10 Cr₹2 Cr₹2 Cr₹5 Cr₹6 Cr₹7 Cr₹11 Cr₹5 Cr₹2 Cr₹5 Cr₹0

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)87.00
Volume (₹)65,274.00
High (₹)88.00
Upper Circuit88.84
Low (₹)87.00
Lower Circuit85.36
Prev Close87.10
52W High (₹)100.94
Price87.00
52W Low (₹)44.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)311.64 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.53
Price to Book1.74
Book Value25.76
EPS (TTM)-2.46
Face Value10.00
ROE (%)-10.64

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
LYKALABS-BENSE
LTP
1W Low
1W High
Market cap (₹)
1849.9+12.6 (0.69%)
1832.20
1891.50
4,47,476Cr
9602+227 (2.42%)
9312.50
9740
2,54,764Cr
4928.5+88.5 (1.83%)
4848.50
5010
1,89,423Cr
1180.3+20.3 (1.75%)
1152.10
1190.60
1,16,658Cr
1399+4.5 (0.32%)
1364.50
1419
1,11,484Cr
2026.2+72.2 (3.69%)
1963.80
2055.30
1,09,943Cr
2500+199.3 (8.66%)
2303
2504.30
1,01,712Cr
1200.4+15.4 (1.30%)
1185
1222
1,01,005Cr
1716-18 (-1.04%)
1689.30
1740
99,253Cr
2100.7+17.7 (0.85%)
2080
2135
96,031Cr
87+3.66 (4.39%)
83.05
88
312Cr

Lyka Labs Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹4.96Cr; with other income of ₹41.9Lakh, profit before interest and tax came to ₹2.96Cr. Interest expense was ₹1.01Cr; PBT before exceptional items stood at ₹1.95Cr. Cost mix (full year): raw materials ₹51.28Cr; employee cost ₹41.85Cr; depreciation ₹2.01Cr; other expenses ₹37.76Cr. Basis: consolidated annual results.

Lyka Labs Ltd Quaterly Results Key Takeaways

Lyka Labs Ltd reported ₹42.31Cr total income from operations in Jun 2026, softer than ₹28.03Cr in Mar 2026 but higher than ₹33.02Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹4.96Cr; with other income of ₹41.9Lakh, profit before interest and tax came to ₹2.96Cr. Interest expense was ₹1.01Cr, taking profit before tax to ₹1.95Cr. After tax of ₹-₹9.9Lakh, profit after tax stood at ₹2.05Cr (vs ₹-₹8.07Cr in Mar 2026 and ₹99.6Lakh in Jun 2025).